DOSE OF REALITY: BIG PHARMA SETS DRUG PRICES, HIKES DRUG PRICES AND BLOCKS COMPETITION TO KEEP DRUG PRICES HIGH
Lawmakers Should Focus on Holding Big Pharma Accountable for Egregious Pricing… Read More
© 2024 CSRXP- All Rights Reserved
CSRXP JOINS FELLOW ADVOCATES FOR LOWER DRUG PRICES TO URGE HOUSE JUDICIARY COMMITTEE TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Letter Encourages Lawmakers to Advance Bipartisan Solutions to Hold Big Pharma… Read More
CSRxP Launches Seven-Figure Advertising Campaign to Hold Big Pharma Accountable for Egregious Drug Prices, Anti-Competitive Tactics and False Rhetoric
Campaign Will Add Support to Growing Bipartisan Momentum to Crack Down on Big… Read More
They Said It! R Street Institute Expert Explains How Big Pharma Games The Patent System to Keep “Drug Prices Artificially High”
New Report Emphasizes The “Pharmaceutical Industry’s Patent Gamesmanship… Read More
CSRxP: Eli Lilly’s Zepbound Announcement Leaves Prices High for Most Patients, Serves as Powerful Reminder Big Pharma Alone Sets Prices
Lowering Prices for Some Patients at Some Dosages Will Have Limited Impact,… Read More
BIG PHARMA EARNINGS WATCH: ELI LILLY & AMGEN
Price Hikes and Egregious Prices on Blockbuster Drugs Boost Profits… Read More
DOSE OF REALITY: BIG PHARMA’S EGREGIOUS GLP-1, GENE, AND CELL THERAPY PRICES PROJECTED TO INCREASE HEALTH CARE COSTS FOR EMPLOYERS
Analysis Finds GLP-1 Blockbusters and “Multimillion-Dollar Gene Therapies”… Read More
BIG PHARMA EARNINGS WATCH: GSK, PFIZER, MERCK, BRISTOL MYERS SQUIBB
Big Pharma Continues Raking in Expectation-Beating Profits and Revenue Fueled… Read More
CSRXP APPLAUDS REINTRODUCTION OF REMEDY ACT IN U.S. SENATE
Bipartisan, Market-Based Solution Would Help Crack Down on Anti-Competitive… Read More
BIG PHARMA EARNINGS: SANOFI, ASTRAZENECA, ROCHE AND ABBVIE
More Brand Name Drug Makers Beat Wall Street Earnings After Hiking Prices This… Read More
BIG PHARMA EARNINGS: JOHNSON & JOHNSON AND NOVARTIS
Big Pharma Giants Top Wall Street Expectations After Hiking Prices on… Read More
CSRXP: BIG PHARMA IS AT IT AGAIN, HIKES PRICES ON NEARLY 200 PRESCRIPTION DRUGS AS PART OF MID-YEAR INCREASES
Brand Name Drug Giants’ Average Price Increases for June-July Outpace Rate… Read More